IP Library › Granted Patent US 9,381,100
Granted Patent B2
US 9,381,100 · App. 13/937,113 · Granted Jul 5, 2016

Implant with increased carbon content at near-surface boundary layer

Inventors: Ullrich Bayer (Admannshagen-Bargeshagen, DE); Bodo Gerold (Zellingen, DE)
Assignee: BIOTRONIK VI PATENT AG
A61F2/82A61L31/022A61L31/084A61L31/148C23C8/20C23C8/22C23C8/24C23C8/26C23C8/30C23C8/32
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,381,100
App. No.
13/937,113
Granted
Jul 5, 2016
Kind
B2
Abstract

Implant in the form of an intraluminal endoprosthesis, having a tubular body containing metallic material, optionally iron, whereby in at least a portion of the implant body the following are present in the structure of a near-surface boundary layer in comparison to the respective concentration in the remaining structure: an increased carbon content in a concentration of approximately 0.5% by weight to approximately 2% by weight; or an increased carbon and nitrogen content, wherein a concentration of carbon is approximately 0.5% by weight to approximately 7% by weight, and a concentration of nitrogen is approximately 0.5% by weight to approximately 17% by weight.

Claims (24)

1. An implant in the form of an intraluminal endoprosthesis, having a tubular body containing metallic material, optionally iron, wherein in at least a portion of the implant body the following are present in the structure of a near-surface boundary layer in comparison to the respective concentration in the remaining structure:

an increased carbon content, wherein a concentration of carbon is approximately 0.5% by weight to approximately 7% by weight, and

an increased nitrogen content, wherein a concentration of nitrogen is approximately 5% by weight to approximately 12% by weight.

2. The implant according to claim 1 , wherein the concentration of carbon is approximately 0.5% by weight to approximately 4% by weight.

3. The implant according to claim 1 , wherein the concentration of carbon is approximately 0.5% by weight to approximately 2% by weight.

4. The implant according to claim 1 , wherein the implant has pores in or near the surface.

5. The implant according to claim 1 , wherein the surface of the implant body has, at least in places, tribochemically applied blast particles or a coating which contains a pharmaceutically active substance.

6. The implant according to claim 1 , wherein the body of the implant has a maximum cementite content of approximately 40% by weight in the boundary layer.

7. The implant according to claim 1 , wherein the boundary layer has a maximum thickness of approximately 20 μm.

8. The implant according to claim 1 , wherein the boundary layer has a maximum thickness of approximately 10 μm.

9. The implant according to claim 1 , further comprising a second portion of the body that at least partially adjoins the boundary layer.

10. An implant in the form of an intraluminal endoprosthesis, having a tubular body containing primarily iron or an iron alloy, wherein in at least a portion of the implant body an increased carbon content is present in the structure of a near-surface boundary layer in comparison to the respective concentration in the remaining structure, wherein a concentration of carbon is approximately 0.5% by weight to approximately 2% by weight.

11. The implant according to claim 10 , wherein the body of the implant is greater than 80% by weight iron.

12. The implant according to claim 11 , wherein the body of the implant is greater than 99% by weight iron.

13. The implant according to claim 10 , wherein the implant has pores in or near the surface.

14. The implant according to claim 10 , wherein the surface of the implant body has, at least in places, tribochemically applied blast particles or a coating which contains a pharmaceutically active substance.

15. The implant according to claim 10 , wherein the boundary layer has a maximum thickness of approximately 20 μm.

16. The implant according to claim 10 , further comprising a second portion of the body that at least partially adjoins the boundary layer.

17. An implant in the form of an intraluminal endoprosthesis, having a tubular body containing primarily iron or an iron alloy, wherein in at least a portion of the implant body the following are present in the structure of a near-surface boundary layer in comparison to the respective concentration in the remaining structure:

an increased carbon, wherein a concentration of carbon is approximately 0.5% by weight to approximately 7% by weight, and

an increased nitrogen content, wherein a concentration of nitrogen is approximately 0.5% by weight to approximately 17% by weight.

18. The implant according to claim 17 , wherein the implant has pores in or near the surface.

19. The implant according to claim 17 , wherein the surface of the implant body has, at least in places, tribochemically applied blast particles or a coating which contains a pharmaceutically active substance.

20. The implant according to claim 17 , wherein the boundary layer has a maximum thickness of approximately 20 μm.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 6, 2018
From: BIOTRONIK VI PATENT AG
To: BIOTRONIK AG
Reel/Frame 045853/0610 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 8, 2013
From: BAYER, ULLRICH; GEROLD, BODO, DR.
To: BIOTRONIK VI PATENT AG
Reel/Frame 030753/0960 →
Continuity (3)
Division 12836068 · Jul 14, 2010
Provisional Application 61246173 · Sep 28, 2009
Related Publication 20130297006A1 · Nov 7, 2013